Vertex to Announce Third Quarter 2024 Financial Results on November 4th
October 10 2024 - 4:05PM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report
its third quarter 2024 financial results on Monday, November 4,
2024 after the financial markets close. The company will host a
conference call and webcast at 4:30 p.m. ET. To access the call,
please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651
(International) and reference the “Vertex Pharmaceuticals Third
Quarter 2024 Earnings Call.”
The conference call will be webcast live and a link to the
webcast can be accessed through Vertex's website at www.vrtx.com in
the "Investors" section. To ensure a timely connection, it is
recommended that participants register at least 15 minutes prior to
the scheduled webcast. An archived webcast will be available on the
company's website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious diseases. The company has approved medicines that
treat the underlying causes of multiple chronic, life-shortening
genetic diseases — cystic fibrosis, sickle cell disease and
transfusion-dependent beta thalassemia — and continues to advance
clinical and research programs in these diseases. Vertex also has a
robust clinical pipeline of investigational therapies across a
range of modalities in other serious diseases where it has deep
insight into causal human biology, including acute and neuropathic
pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal
dominant polycystic kidney disease, type 1 diabetes and myotonic
dystrophy type 1.
Vertex was founded in 1989 and has its global headquarters in
Boston, with international headquarters in London. Additionally,
the company has research and development sites and commercial
offices in North America, Europe, Australia, Latin America and the
Middle East. Vertex is consistently recognized as one of the
industry's top places to work, including 14 consecutive years on
Science magazine's Top Employers list and one of Fortune’s 100 Best
Companies to Work For. For company updates and to learn more about
Vertex's history of innovation, visit www.vrtx.com or follow us on
LinkedIn, Facebook, Instagram, YouTube and X.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241010368265/en/
Vertex Pharmaceuticals Incorporated Investor Relations:
investorinfo@vrtx.com
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Nov 2024 to Dec 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Dec 2023 to Dec 2024